QuidelOrtho Corp
Nasdaq · Healthcare · In Vitro & In Vivo Diagnostic Substances · San Diego, CA
QDEL chart
What traders are saying about $QDEL
Latest postsQuidelOrtho Corp news
- QDEL Q2 2026 Earnings: Loss Forecast Flips to a Profit as EPS Surprise Tops 374% - Earnings Season Review
https://www.dars.gov.et/ ·
- QuidelOrtho Corporation Estimates – NASDAQ:QDEL
TradingView ·
- 3 unprofitable stocks walking a fine line
Yahoo Finance ·
- What Investors Got Wrong About QuidelOrtho Before A 53% Slide
Simply Wall Street ·
- QuidelOrtho Corporation (QDEL) stock price, news, quote and history
Yahoo Finance Singapore ·
- Why Are Intuitive Surgical (NASDAQ:ISRG), QuidelOrtho (NASDAQ:QDEL), MannKind (NASDAQ:MNKD) and Praxis (NASDAQ:PRAX) Moving Before the Open?
kalkine.ca ·
- QuidelOrtho Shares Rise More Than 11% After Friday's 7% Drop
TOKENPOST ·
- QuidelOrtho Corporation (QDEL) Stock Forecasts
Yahoo Finance ·
- QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
Yahoo Finance ·
- Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
Yahoo Finance ·
- QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Reasons to Add QuidelOrtho Stock to Your Portfolio for Now
Yahoo Finance ·
QuidelOrtho Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.73B | $2.78B | $3.00B | $3.27B |
| Net income | -$1.13B | -$2.05B | -$10.1M | $548.7M |
| Diluted EPS | $-16.69 | $-30.54 | $-0.15 | $9.56 |
| Total assets (year end) | $5.77B | $6.42B | $8.56B | $8.86B |
| Cash and equivalents (year end) | $169.8M | $98.3M | $118.9M | $292.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About QuidelOrtho Corp
- Ticker
- QDEL (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- San Diego, CA
- Fiscal year end
- January 1
- SEC CIK
- 1906324
- Former names
- Coronado Topco, Inc.
Frequently asked questions
What exchange is QuidelOrtho Corp listed on?
QuidelOrtho Corp trades on the Nasdaq under the ticker symbol QDEL.
What industry is QuidelOrtho Corp in?
QuidelOrtho Corp is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is QuidelOrtho Corp headquartered?
QuidelOrtho Corp's business address on file with the SEC is in San Diego, CA.
When does QuidelOrtho Corp's fiscal year end?
QuidelOrtho Corp's fiscal year ends on January 1.
How much revenue did QuidelOrtho Corp report?
QuidelOrtho Corp reported $2.73B in revenue for calendar year 2025, according to its SEC filings.